Vanguard Personalized Indexing Management, LLC Amicus Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 17,887 shares of FOLD stock, worth $108,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,887
Previous 10,955
63.28%
Holding current value
$108,395
Previous $89,000
14.61%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FOLD
# of Institutions
309Shares Held
321MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$177 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$148 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$130 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$124 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.7B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...